DIVEMA-methotrexate: immune-adjuvant role of polymeric carriers linked to antitumor agents.
D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology; D011108:Polymers / Q000008:administration & dosage*; D011713:Pyran Copolymer / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D011108:Polymers; D011713:Pyran Copolymer; D008727:Methotrexate